GCG and Hypoglycemia: The reduction in nocturnal hypoglycemia events associated with IGlar use is a significant clinical advantage as deaths from hypoglycaemia are not uncommon in low resource countries due to factors including food insecurity, limited self-monitoring of blood glucose, lack of access to glucagon, and limited after-hours access to emergency services [25,26].